Economic Atlas
Companies/Arbutus Biopharma Corp
Company profile

Arbutus Biopharma Corp

NASDAQ: ABUS · Healthcare · Biotechnology
PublicHQ Warminster, PACIK 0001447028Reports USD
#588 of 1,417 Healthcare companies by revenuetop-quartile growth
EA Score
61C
Revenue TTM
$191.4M
Rev growth YoY (TTM)
+2889.9%
Net income (FY)
-$33.5M
Employees
19
as of 2026-08-10
Market cap
$914.6M
as of 2026-08-10

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$14.1M$14.1M2025
Net income-$33.5M-$33.5M2025
Operating income-$38.2M-$38.2M2025
Total assets$94.6M$94.6M2025
Liabilities$18.0M$18.0M2025
Equity$76.6M$76.6M2025

Revenue trend

FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2025
By product
License82%
Non-Cash Royalty12%
Service, Other6%
By geography

Not disclosed.

The read

What is Arbutus Biopharma Corp’s revenue?

Arbutus Biopharma Corp booked $14.1M in FY2025 revenue, growing 128% year over year — faster than most Healthcare companies we track, at a -237.9% net margin.

Peers · Healthcare
Sunniva Inc.——Urologix, Inc.——Opus Genetics, Inc.39DHealthcare Triangle, Inc.40DPyxis Oncology, Inc.28DBiotricity, Inc.——
Key facts
CEOLindsay Androski
SectorHealthcare
IndustryBiotechnology
HeadquartersWarminster, PA
ExchangeNASDAQ: ABUS
Employees19
IPO date2007-07-26
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.